Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Subscribe to see Immatics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Immatics is a biotech company headquartered in Tuebingen, Germany. It is publicly listed (IMTX) with a market capitalisation of $1.1B. Xcout tracks 33 named people at Immatics, including Harpreet Singh (Chief Executive Officer, MD, Member of Management Board & Executive Director). Xcout recorded 4 job postings from Immatics in the last 90 days.
27 more named people on record for Immatics, with roles, board committees and tenure — see the full roster →
Xcout recorded 4 job postings from Immatics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Immatics's hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.